ES2054263T3 - Composicion trombolitica conteniendo activador de plasminogeno del tipo de tejido o uno de sus derivados. - Google Patents

Composicion trombolitica conteniendo activador de plasminogeno del tipo de tejido o uno de sus derivados.

Info

Publication number
ES2054263T3
ES2054263T3 ES90310288T ES90310288T ES2054263T3 ES 2054263 T3 ES2054263 T3 ES 2054263T3 ES 90310288 T ES90310288 T ES 90310288T ES 90310288 T ES90310288 T ES 90310288T ES 2054263 T3 ES2054263 T3 ES 2054263T3
Authority
ES
Spain
Prior art keywords
salt
same
derivatives
composition containing
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90310288T
Other languages
English (en)
Inventor
Yokio Shimazaki
Miyuki Kawashima
Masahiko Ishibashi
Ryo Tanaka
Kiyoshi Sakai
Hisahiro Ishiwari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Mochida Pharmaceutical Co Ltd
Original Assignee
Mitsui Toatsu Chemicals Inc
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc, Mochida Pharmaceutical Co Ltd filed Critical Mitsui Toatsu Chemicals Inc
Application granted granted Critical
Publication of ES2054263T3 publication Critical patent/ES2054263T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN COMPUESTO TROMBOLITICO CONTENIENDO TEJIDO DE TIPO ACTIVADOR PLASMINOGENO O UN DERIVADO DEL MISMO EN COMBINACION CON UN POLIMERO ANIONICO O UNA SAL DEL MISMO Y UN COMPUESTO AMINO O UNA SAL DEL MISMO O EN COMBINACION CO CON UN POLIMERO ANIONICO O UNA SAL DEL MISMO, UN COMPUESTO AMINO Y UN ACIDO O UNA SAL DEL MISMO. EL COMPUESTO ES UNA SOLUCION ACUOSA O UNA PREPARACION LIOFILIZADA QUE PUEDE SER DISUELTA DE FORMA ESTABLE EN UNA DISOLUCION A UN PH NEUTRO TANTO EN SOLUCIONES FARMACEUTICAS QUE TENGAN ALTAS CONCENTRACIONES DE SAL, TALES COMO EL SUERO FISIOLOGICO SALINO, COMO EN SOLUCIONES FARMACEUTICAS QUE TENGAN UNA BAJA CONCENTRACION EN SAL, TALES COMO UNA SOLUCION DE GLUCOSA AL 5%. PRODUCTOS CLINICAMENTE UTILES PARA SU INFUSION O INYECCION SE PREPARAN PARA USARSE A UN PH SENSIBLEMENTE NEUTRO.
ES90310288T 1989-09-21 1990-09-20 Composicion trombolitica conteniendo activador de plasminogeno del tipo de tejido o uno de sus derivados. Expired - Lifetime ES2054263T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24331089 1989-09-21

Publications (1)

Publication Number Publication Date
ES2054263T3 true ES2054263T3 (es) 1994-08-01

Family

ID=17101932

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90310288T Expired - Lifetime ES2054263T3 (es) 1989-09-21 1990-09-20 Composicion trombolitica conteniendo activador de plasminogeno del tipo de tejido o uno de sus derivados.

Country Status (15)

Country Link
US (1) US6051223A (es)
EP (1) EP0419252B1 (es)
JP (1) JP2520975B2 (es)
KR (1) KR930008908B1 (es)
CN (1) CN1041799C (es)
AT (1) ATE86867T1 (es)
BR (1) BR9004692A (es)
CA (1) CA2025317C (es)
DE (1) DE69001110T2 (es)
DK (1) DK0419252T3 (es)
ES (1) ES2054263T3 (es)
FI (1) FI104953B (es)
GR (1) GR3007396T3 (es)
NO (1) NO904119L (es)
NZ (1) NZ235298A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
US5272076A (en) * 1991-06-13 1993-12-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6533767B2 (en) * 2000-03-20 2003-03-18 Corazon Technologies, Inc. Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
US8110596B2 (en) * 2006-03-27 2012-02-07 Tokyo University Of Agriculture And Technology Tlo Co., Ltd. Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
AU2013274406B2 (en) * 2012-06-11 2017-02-02 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
CN103191054B (zh) * 2013-04-19 2015-05-27 范克 一种肝素钠封管注射液及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310133A2 (fr) * 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne
JPS52145591A (en) * 1976-05-28 1977-12-03 Kanebo Ltd Stabilization of urokinase
JPS5467089A (en) * 1977-11-07 1979-05-30 Dainippon Pharmaceut Co Ltd Urokinase composition
JPS5568290A (en) * 1978-11-16 1980-05-22 Kanebo Ltd Stabilization of urokinase
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
JPS60158116A (ja) * 1984-01-30 1985-08-19 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60158117A (ja) * 1984-01-30 1985-08-19 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60181028A (ja) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法
JPS60184026A (ja) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法
WO1986005095A1 (en) * 1985-03-06 1986-09-12 Survival Technology, Inc. t-PA COMPOSITION AND METHOD OF GETTING INTO BLOOD STREAM
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
DE3512909A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung von plasminogenaktivatoren (pa)
ATE83153T1 (de) * 1985-09-10 1992-12-15 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
JPH0669960B2 (ja) * 1985-11-22 1994-09-07 エーザイ株式会社 水溶性を増加したｔＰＡ含有医薬組成物
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 ｔＰＡ医薬組成物
JPS62292729A (ja) * 1986-06-12 1987-12-19 Toyobo Co Ltd ヒト子宮組織由来プラスミノ−ゲン活性化因子製剤
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH06226234A (ja) * 1993-02-01 1994-08-16 Shojiro Takeuchi 産業廃棄物の炭化処理方法
JPH06236332A (ja) * 1993-02-09 1994-08-23 Oki Electric Ind Co Ltd プログラムローディング装置
JPH06259221A (ja) * 1993-03-05 1994-09-16 Tokyo Electric Co Ltd 画面表示器を備えた情報処理装置
JPH06281326A (ja) * 1993-03-30 1994-10-07 Shibaura Eng Works Co Ltd 洗浄物の乾燥方法

Also Published As

Publication number Publication date
KR930008908B1 (ko) 1993-09-17
FI104953B (fi) 2000-05-15
ATE86867T1 (de) 1993-04-15
EP0419252B1 (en) 1993-03-17
AU619697B2 (en) 1992-01-30
JPH0418032A (ja) 1992-01-22
GR3007396T3 (es) 1993-07-30
CN1041799C (zh) 1999-01-27
DE69001110D1 (de) 1993-04-22
BR9004692A (pt) 1991-09-10
KR910005883A (ko) 1991-04-27
NO904119D0 (no) 1990-09-20
CA2025317C (en) 1996-05-07
DE69001110T2 (de) 1993-06-24
US6051223A (en) 2000-04-18
DK0419252T3 (da) 1993-04-19
CN1050321A (zh) 1991-04-03
CA2025317A1 (en) 1991-03-22
AU6246790A (en) 1991-03-28
NZ235298A (en) 1992-12-23
NO904119L (no) 1991-03-22
JP2520975B2 (ja) 1996-07-31
EP0419252A1 (en) 1991-03-27
FI904617A0 (fi) 1990-09-19

Similar Documents

Publication Publication Date Title
DE60036017T2 (de) Verfahren zur thrombolyse durch lokale behandlung mit reversibel inaktiviertem, angesäuertem plasmin
ES2009378A6 (es) Metodo de preparar una composicion util para aplicacion al cabello o ala piel.
ES2054263T3 (es) Composicion trombolitica conteniendo activador de plasminogeno del tipo de tejido o uno de sus derivados.
SE8701921D0 (sv) Ny farmaceutisk anvendning
GR3004869T3 (es)
DE59509580D1 (de) Pharmazeutisches präparat enthaltend plasminogenaktivatoren
IL90146A0 (en) Variants of plasminogen activators and processes for their production
HUT67321A (en) Transdermal preparations containing lanolin derivatives as penetration- promoting agent
IT8322623A1 (it) Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
FR2440194A1 (fr) Preparation pharmaceutique injectable contenant des aminoacides
GB1453343A (en) Anaesthetic compositions and their use
FI98123B (fi) Menetelmä ihmisen kudosplasminogeeniaktivaattorin valmistamiseksi
GB1294299A (en) Isoniazid derivative
ATE137971T1 (de) Verfahren zum herstellen von arzneizusammensetzungen, die vecuroniumbromid enthalten
Brown jr Comparison of diffusion of different microbial growth factors, alone and in combination, through extracted human teeth
SU1515606A1 (ru) Способ очистки и выделения нитропруссида натрия
Barr et al. In vitro antifibrinolytic activity of various compounds
ES2307561T3 (es) Preparacion liquida estabilizada de la proteasa activadora del factor vii de la coagulacion sanguinea, o de su proenzima.
GB1449228A (en) Conservation of blood
GB668850A (en) Improved process for producing laevulose-containing solutions for injection purposes
Kandhari et al. Demonstration of proteolytic enzymes in epidermal extracts capable of producing splits in skin
ES415972A1 (es) Procedimiento para la preparacion de soluciones inyectablesde complejos de indicacion antineuritica, de vitaminas, co- fermentos, y sus asociaciones.
ATE190837T1 (de) Aminosäureergänzung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 419252

Country of ref document: ES